Skip to main content

Table 3 Comparison of survivals in different groups who received heart transplantation for primary cardiac sarcoma with or without chemotherapy

From: Survival after heart transplantation for non-metastatic primary cardiac sarcoma

Patients Survival (mo) median (range), (cases) Log-rank P value
Neoadjuvant chemotherapy Yes No  
 All 15 (2–84), (n–18) 18 (2–112), (n = 27) 0.210
 Non-angiosarcoma 36 (5–84), (n = 8) 43 (2–112), (n = 22) 0.462
 Grade3 7 (5–37), (n = 6) 15 (2–43), (n = 9) 0.731
Adjuvent chemotherapy Yes No  
 All 15 (5–36), (n = 11) 36 (2–112), (n = 34) 0.088
 Non-angiosarcoma 18 (18–36), (n = 2) 37 (2–112), (n = 28) 0.407
 Grade3 10 (5–18), (n = 5) 16 (2–43), (n = 10) 0.169
  1. Values are presented as median (range)